R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Manager – Global Study Start-Up

Clinical Research OperationsConfirmed live in the last 24 hours
Full-time$114.8k - $187.4k /yr

About the Job

Requirements

  • Demonstrated interpersonal and leadership skills.
  • Ability to understand and implement the operational strategic direction and guidance for clinical studies.
  • Ability to use a data-driven approach to planning, execution, and problem-solving.
  • Effective verbal, written, and presentation communication skills.
  • Ability to meet deadlines, manage time effectively, and prioritize work proactively and with self-discipline.
  • Ability to influence and negotiate across key stakeholders.
  • Ability to build productive study-team collaborations.
  • Experience in the clinical drug development process, with expertise in study start-up.
  • Demonstrated vendor-management experience.
  • Technical proficiency in trial management systems, including CTMS and TMF, and Microsoft Project, PowerPoint, Word, and Excel.
  • Knowledge of ICH/GCP and regulatory guidelines and directives.
  • Effective project-management, cross-functional team interaction, and organizational skills.

Responsibilities

  • Develop site start-up strategy for each study, identify dependencies affecting site activation, and mitigate or escalate risks.
  • Track and analyze study metrics, including risks and mitigation strategies, to evaluate CRO performance and implement corrective actions.
  • Advocate for optimized site-selection strategies and use data-driven insights to guide cross-functional decisions.
  • Lead development, assessment, and alignment of site-activation projections in collaboration with cross-functional teams and CROs.
  • Ensure site start-up materials are documented in the Trial Master File to maintain inspection readiness.
  • Partner with cross-functional and CRO teams to develop global country start-up strategies, identify dependencies, and mitigate or escalate risks.
  • Monitor and maintain country-intelligence data to inform decisions and develop start-up projections and strategic plans.
  • Support regulatory submissions by providing site documentation, coordinating submissions to Central Institutional Review Boards, supporting sites with Local Institutional Review Board submissions, and handling or supervising CRO insurance requests.
  • Ensure timely country-submission deliverables, including task completion, role clarity, identification of critical-path items, and effective communication pathways.
  • Lead and oversee site start-up activities, including fast-track site initiation, site calls, document collection, and milestone tracking.
  • Serve as a subject-matter expert for essential site documents and provide teams and sites with training, guidance, and support on regulatory requirements, document management, and TMF filing.
  • Oversee CRO site start-up management or the in-house site-facing regional SSU team, where applicable.
  • Lead the collection and analysis of site intelligence to support strategic site selection and site start-up.
  • Oversee preparation and approval of site regulatory packages, ensuring compliance with country-specific requirements, TMF standards, and ICH-GCP guidelines, and supporting inspection readiness and high-quality site documentation.
  • Represent Site Start-Up on cross-functional teams, provide updates, escalate challenges, and propose mitigation strategies for site start-up issues.
  • Act as the escalation point for CRO and internal teams to ensure timely resolution of site start-up issues.
  • Recommend and participate in cross-functional and departmental process improvements.
  • Travel up to 25% as required.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs